pacman schreef op 25 juni 2021 09:41:
Goed nieuws voor Pharming ,misschien wel zeer goed nieuws,
FDA Authorizes Drug for Treatment of COVID-19
Jun 24, 2021, 19:40 ET
SHARE THIS ARTICLE
SILVER SPRING, Md., June 24, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug Actemra (tocilizumab) for the treatment of hospitalized adults and pediatric patients (2 years of age and older) who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). Actemra is not authorized for use in outpatients with COVID-19.
www.prnewswire.com/news-releases/coro...- - -
remember,
To effectively treat the “Citokine Storm” Tocilizumab (Actemra) has been used to block the pro-inflammatory action of Il-6, and seems to have been helpful in anecdotal cases (3 patients treated in Italy). C1-esterase Inhibitor (Berinert, Cynrize,
Ruconest) could also be tested to see if it is capable slow the inflammatory response.